Shanghai
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
Search
COVID-19 Once a nurse always a nurse
Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
All the same, yet different – Ethnic Equality Month
Mohammed Samy, Human Pharma Marketing Team Lead from Amsterdam explains how ethnic diversity creates collective strength and sustainable growth. Read more.
EFPIA disclosure
Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations and disclosures of transfers of value (ToVs) to HCPs and HCOs.
COVID-19 material donations Germany
Boehringer Ingelheim provides the Corona special hospital in Ingelheim on a daily basis with free food for medical staff. Click here to learn more.
Back to life
Anna Higgs had a severe stroke at the age of 24. For years she has been struggling with the consequences. Click here to learn more about her story.
Management Systems
Suppliers shall use management systems to support continuous improvement and compliance with the supplier code of conduct. Click here to learn more.
What can the patient do?
Be aware and know your source.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects. Click here to find out more information and learn more.
Green Chemistry
Green Chemistry is critical for us as it balances the long-term sustainability of business, society, and the environment. Click here to learn more.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks are in the news.
FuturePack
Boehringer Ingelheim has built a new special machine that enables efficient and sustainable packaging of small batches. Learn more about this here.
Vienna
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Vienna site.
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
COVID-19 RCV thank you
A big thank you to all doctors, all nurses and all others working in the healthcare sector from the employees of BI Regional Centre Vienna. Read more here!
COVID-19 BI Cares Foundation
BI Cares is making monetary donations and donating urgently needed medicines for patients through our NGO partners during the pandemic. Learn more.
Commits to Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
Circular economy
Plastic pollution is one of the most serious threats to the world’s oceans. Click here to find out how long it takes for garbage to dissolve in the oceans!
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
Marek's Disease Poultry Chicken
Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. Learn more here.
pet care digital age
Pets can be family members, trusted companions – and they are also part of a large global industry. Learn more about pet care in the digital age here.
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
Boehringer Ingelheim - Value Through Innovation
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here to learn more.